High-Sensitivity CRP
A marker of low-grade inflammation
Overview
hs-CRP is a high-sensitivity measure of C-reactive protein, a liver-made protein that rises with inflammation. The high-sensitivity assay can detect the low-grade inflammation relevant to cardiovascular risk.
Why it matters
Chronic low-grade inflammation contributes to atherosclerosis, and hs-CRP adds independent information to cholesterol-based risk. It is non-specific, however — many things raise it — so it is interpreted alongside the broader picture.
New to this? Read these first
How this usually unfolds
- Measure it
- Understand your result
- See what raises and lowers it
- Apply evidence-based interventions
- Recheck on your review cadence
Where the evidence points
< 1 mg/L lower cardiovascular risk; 1–3 mg/L average; > 3 mg/L higher risk. Values > 10 mg/L usually reflect acute infection or injury — retest when well.
hs-CRP is non-specific: infection, injury, obesity, and recent illness all raise it. A single high value should be rechecked before conclusions.
Clinical interpretation
A persistently elevated hs-CRP (with acute causes excluded) suggests ongoing inflammation and can refine cardiovascular risk, particularly when other factors are borderline. It does not identify the source of inflammation.
What raises and lowers it
Raises it
- Acute infection or injury
- Obesity and insulin resistance
- Smoking
- Chronic inflammatory conditions
Lowers it
- Weight loss
- Regular exercise
- Smoking cessation
- Statins (as an anti-inflammatory effect) and treatment of the underlying cause
How this connects across BioSignal
Related Foundations
Related Signal Records
Related biomarkers
Related comparisons
Related body systems
Related conditions
Related pharmaceuticals
Related lifestyle interventions
Diagnostics
- High-sensitivity blood assay
- Best measured when free of acute illness; repeat to confirm
Frequently asked questions
Does a high hs-CRP mean I have heart disease?
Not by itself. It signals inflammation, which can come from many sources. Once acute causes are excluded, a persistently high level can add to cardiovascular risk assessment.
Evidence summary
hs-CRP predicts cardiovascular events independently of cholesterol, and a landmark trial showed benefit from statin therapy in people selected partly by elevated hs-CRP — though it remains a non-specific marker.
References & sources
- AHA/CDC Scientific Statement on inflammation markers
- 2018 ACC/AHA Cholesterol Guideline (risk-enhancing factors)
Educational information — not medical advice
Is this biomarker page clear, accurate, and useful? Your feedback shapes what we review next.
Give feedback